|
C13ORF37 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.951800E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.125000E-01 |
| Normal-vs-Stage2 |
1.617040E-01 |
| Normal-vs-Stage3 |
8.611400E-01 |
| Normal-vs-Stage4 |
2.491400E-01 |
| Stage1-vs-Stage2 |
3.234600E-01 |
| Stage1-vs-Stage3 |
4.430400E-01 |
| Stage1-vs-Stage4 |
7.037200E-01 |
| Stage2-vs-Stage3 |
1.849600E-01 |
| Stage2-vs-Stage4 |
4.326800E-01 |
| Stage3-vs-Stage4 |
3.015800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.876760E-01 |
| Normal-vs-AfricanAmerican |
1.656230E-01 |
| Normal-vs-Asian |
5.985000E-01 |
| Caucasian-vs-AfricanAmerican |
1.100450E-03 |
| Caucasian-vs-Asian |
9.650200E-01 |
| AfricanAmerican-vs-Asian |
1.633800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.877590E-01 |
| Normal-vs-Female |
9.108400E-01 |
| Male-vs-Female |
9.615600E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.937400E-01 |
| Normal-vs-Age(41-60Yrs) |
3.132400E-01 |
| Normal-vs-Age(61-80Yrs) |
3.353600E-01 |
| Normal-vs-Age(81-100Yrs) |
9.153000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.461400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.212000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.901400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.950400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.893800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.218000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
4.393800E-01 |
| Normal-vs-Grade 2 |
9.132100E-02 |
| Normal-vs-Grade 3 |
5.751600E-01 |
| Normal-vs-Grade 4 |
7.173400E-01 |
| Grade 1-vs-Grade 2 |
8.120600E-01 |
| Grade 1-vs-Grade 3 |
5.460200E-01 |
| Grade 1-vs-Grade 4 |
2.885400E-01 |
| Grade 2-vs-Grade 3 |
1.040350E-01 |
| Grade 2-vs-Grade 4 |
2.871800E-02 |
| Grade 3-vs-Grade 4 |
2.870200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.477600E-02 |
| Normal-vs-ccB subtype |
8.752600E-01 |
| ccA subtype-vs-ccB subtype |
2.376000E-03 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.832600E-01 |
| Normal-vs-N1 |
6.752200E-01 |
| N0-vs-N1 |
9.697200E-01 |
|
|
